Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia-Reference-Cited by-同舟云学术

Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia

Published:2021-05 Issue:5 Volume:21 Page:328-337.e1
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Gómez García Lara Maria,Escudero Adela,Mestre Carmen,Fuster Soler Jose L.,Martínez Antonia Pascual,Vagace Valero Jose M.,Vela María,Ruz Beatriz^ORCID,Navarro Alfonso^ORCID,Fernández Lucia,Fernández Adrián,Leivas Alejandra^ORCID,Martínez-López Joaquin,Ferreras Cristina,De Paz Raquel,Blanquer Miguel,Galán Victor,González Berta,Corral Dolores,Sisinni Luisa,Mirones Isabel^ORCID,Balas Antonio,Vicario José Luis,Valle Paula,Borobia Alberto M.,Pérez-Martínez Antonio

Funder

Fundación Mutua Madrileña

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference43 articles.

1. Pediatric AML: from biology to clinical management;de Rooij;J Clin Med,2015

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

3. A critical review of which children with acute myeloid leukaemia need stem cell procedures;Hasle;Br J Haematol,2014

4. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel;Creutzig;Blood,2012

5. New and emerging targeted therapies for pediatric acute myeloid leukemia (AML);Chen;Children,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Treatment Options and Communication in Relapsed Pediatric AML;American Society of Clinical Oncology Educational Book;2024-06

2. Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies;Experimental Hematology & Oncology;2024-02-23

3. Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion;Anticancer Research;2023-08-30

4. Expanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations;Molecular Therapy - Oncolytics;2023-03

5. Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox;Cancers;2022-11-17